Ellence and po2 decreased Patient Reports February 12, 2012

Ellence Side Effects Report #4665400-3
Ellence side effect was reported by a Health Professional from on May 09, 2005. Female patient, 47 years of age, weighting 198.4 lb, was diagnosed with breast cancer  and was treated with Ellence. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiomyopathy , condition aggravated, ejection fraction decreased, electrocardiogram abnormal, hypertension, po2 decreased. Ellence dosage: 75 MG/M2 (75 MG/M2, CYCLIC, EVERY 21 DAYS), INTRAVENOUS. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Ellence Side Effects Report #4676737-6
Ellence side effect was reported by a Health Professional from on May 20, 2005. Female patient, 47 years of age, weighting 198.4 lb, was diagnosed with breast cancer  and was treated with Ellence. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiomyopathy , electrocardiogram q wave abnormal, hypertension, po2 decreased. Ellence dosage: 75 MG/M2 (75 MG/M2, CYCLIC, EVERY 21 DAYS), INTRAVENOUS. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.